Contact
searchSearch
HMP Global

Inflammatory Bowel Disease Topic Center

News
Subcutaneous Ustekinumab Cost Rose 84% Under Medicare Part D, Set to Drop Under Negotiated Price Reduction
08/15/2024
Coverage changes omitted self-injected therapies from Part B, but new negotiated price will reduce costs 66-67%.
Coverage changes omitted self-injected therapies from Part B, but new negotiated price will reduce costs 66-67%.
Coverage changes omitted...
08/15/2024
Rheumatology & Arthritis
From Rheumatology & Arthritis
Conference Coverage
IMID Symptoms—Beyond the Physical
06/22/2023
Immune mediated inflammatory disease symptoms are more than just physiological, extending from anxiety to depression to fatigue.
Immune mediated inflammatory disease symptoms are more than just physiological, extending from anxiety to depression to fatigue.
Immune mediated inflammatory...
06/22/2023
Autoimmune
Uma Mahadevan, MD
Conference Coverage
Considerations in Managing Pregnancy Among Patients with IMIDs
06/21/2023
Uma Mahadevan, MD, and Christopher Robinson, MD, discuss the importance of preconception counseling for a patient with immune-mediated inflammatory disease to boost their chances of achieving and maintaining a healthy pregnancy.
Uma Mahadevan, MD, and Christopher Robinson, MD, discuss the importance of preconception counseling for a patient with immune-mediated inflammatory disease to boost their chances of achieving and maintaining a healthy pregnancy.
Uma Mahadevan, MD, and...
06/21/2023
Autoimmune
Stephen Hanauer
Conference Coverage
Breaking Through the Therapeutic Ceiling: the Future of Inflammatory Bowel Disease
04/28/2023
A panel led by inflammatory bowel disease specialists Stephen B. Hanauer and Adam Cheifetz reviewed the importance of working to break through a therapeutic ceiling and developing precision medicine in propelling the practice of...
A panel led by inflammatory bowel disease specialists Stephen B. Hanauer and Adam Cheifetz reviewed the importance of working to break through a therapeutic ceiling and developing precision medicine in propelling the practice of...
A panel led by inflammatory...
04/28/2023
Autoimmune
multidisciplinary healthcare
Conference Coverage
Combined Clinics – Combined Management Strategies
04/27/2023
Comanagement strategies are often beneficial to patients with immune-mediated inflammatory disease since they are at a higher risk of developing other autoimmune conditions.
Comanagement strategies are often beneficial to patients with immune-mediated inflammatory disease since they are at a higher risk of developing other autoimmune conditions.
Comanagement strategies are...
04/27/2023
Autoimmune
Stephen Hanauer
Conference Coverage
Stephen B. Hanauer, MD, on Human Models of Inflammatory Bowel Disease
04/26/2023
Dr Hanauer emphasizes how a number of potential human models can be used to more accurately evaluate the pathogenesis of inflammatory bowel disease by studying human patients rather than mice.
Dr Hanauer emphasizes how a number of potential human models can be used to more accurately evaluate the pathogenesis of inflammatory bowel disease by studying human patients rather than mice.
Dr Hanauer emphasizes how a...
04/26/2023
Autoimmune
Gil Melmed, MD
Conference Coverage
Gil Melmed, MD, on COVID-19 Vaccination Responses and Safety in Patients with IBD
12/21/2022
Dr Melmed reviews the results of studies regarding the response to and safety of COVID-19 vaccination among patients with IBD.
Dr Melmed reviews the results of studies regarding the response to and safety of COVID-19 vaccination among patients with IBD.
Dr Melmed reviews the results of...
12/21/2022
Autoimmune
News
IL-17 Inhibitors Examined for Association With IBD
08/31/2021
Researchers in France investigated whether treating inflammatory arthritis with interleukin-17 inhibitors might increase risk of inflammatory bowel disease.
Researchers in France investigated whether treating inflammatory arthritis with interleukin-17 inhibitors might increase risk of inflammatory bowel disease.
Researchers in France...
08/31/2021
Autoimmune
News
Patients With IMIDs Have Positive Perception of Nutrition on IBD Symptom Management
08/26/2021
Patients with IMIDs acknowledge the importance of nutrition and its importance on symptom management but need more dietary advice from HCPs.
Patients with IMIDs acknowledge the importance of nutrition and its importance on symptom management but need more dietary advice from HCPs.
Patients with IMIDs acknowledge...
08/26/2021
Autoimmune
News
Risk of IBD Higher With Apremilast, Lower With Etanercept for Psoriasis, PsA, and AS
08/20/2021
Risk of developing inflammatory bowel disease is greater among new users of IL-17 inhibitors than among new users of apremilast but not in etanercept new-users.
Risk of developing inflammatory bowel disease is greater among new users of IL-17 inhibitors than among new users of apremilast but not in etanercept new-users.
Risk of developing inflammatory...
08/20/2021
Autoimmune
Jason Schairer, MD, on Dermatologic Manifestations in IBD
Q&As
Jason Schairer, MD, on Dermatologic Manifestations in IBD
06/06/2021
In this Q&A, Dr Schairer answers our questions about the presentation, diagnosis, and treatment of dermatological conditions among patients with inflammatory bowel disease.
In this Q&A, Dr Schairer answers our questions about the presentation, diagnosis, and treatment of dermatological conditions among patients with inflammatory bowel disease.
In this Q&A, Dr Schairer answers...
06/06/2021
Autoimmune

Sign Up for our e-Newsletter

Autoimmune Newsletter

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use